Background: Cervical cancer has decreased in developed countries thanks to cytology screening programmes. The aims of this study were To analyse the frequency and evolution of performing cytology tests and to determine the variables that influence their use. Methods: Cross-sectional study of non-institutionalized women who participated in the national health survey (2006, 2011/12) and the European Health Survey in Spain (2009Spain ( , 2014. Study variables: cytology-testing, time since last cytology-test, reason for performing the test, age, nationality, marital status, social status, education level and place of residence. Results: The study evaluated 53 628 women in Spain over 15 years old, with a mean age of 52.68 (SD AE 19.12). About 94.1% were Spanish, 49.2% were married and 77.2% lived with a partner. In 2014, 72% had a cytology test, a number that increased significantly. Women aged 25-65 were 5.13 times more likely to undergo a cytology test than those aged 15-24 years old (odds ratio (OR): 5.13; P < 0.001); women with university educations were 9.23 times more likely to undergo a cytology test than those without university educations (P > 0.001); those of social classes I and II (high) were 1.2 more likely to undergo a cytology test than those of low social class (P = 0.026); and Spanish women were 1.74 times more likely to undergo a cytology test than foreigners living in Spain (P < 0.001). Conclusion: Frequency of cytology testing has increased in the last few years. Screening for cervical cancer is associated with higher social status, education level, age, and not being foreign.
Introduction
C ervical cancer has a high incidence worldwide, being the third most frequent type of cancer in women and the second cause of cancer-related mortality in women. 1, 2 In 2012, approximately 527 600 cases were diagnosed worldwide. The incidence varies between countries, with developing countries having the highest incidence (444 500 deaths). The worldwide mortality due to cervical cancer is 265 700 deaths and is also higher in developing countries (230 200 deaths). 2, 3 In USA, it was estimated that in 2016, 12 990 cases would be diagnosed, with 4120 deaths from cervical cancer. 1 In Western European countries, the incidence has been decreasing, 4, 5 especially in Spain, which has the lowest occurrence of cervical cancer. 5, 6 However, the incidence has increased in the countries of Eastern Europe. [5] [6] [7] Generally, in developed countries, although the incidence of cervical cancer in older women (> 55 years) has declined, there has been an increase in younger women aged 30-35 years. 4, 8, 9 These differences in the incidence of cervical cancer among different countries (developed and developing) can be explained by the inequality of health systems' capacities to establish programmes for the early detection of cancerous lesions and human papillomavirus (HPV) infection. 2, 9 Cervical cancer is associated with HPV infection. 10 The prevalence of HPV infection also differs among countries, varying from 9 to 21% in Africa, Latin America and Southeast Asia to approximately 5% in the United States. 11 In Spain, in recent years, the prevalence of HPV infection has increased to 14.3%, of which 28.8% are women between 18 and 25 years old. 12 This increase in recent years may be due to changes in the sexual behaviour of young women (i.e. sexual initiation at earlier ages and greater numbers of sexual partners). 13 Screening programmes have been in place in Europe since the 1980 s, Norway, Finland and the Netherlands were the first ones. 14 In the different countries where population-based screening programmes have been established (the Netherlands, 15 Italy, 16 Denmark, 4 Norway 14 and Sweden
14
), the mortality due to cervical cancer has been reduced.
As mentioned previously, Spain is among the countries with the lowest rates of cervical cancer, 5 which is the reason because population-based screening programmes have not been scheduled. 17 The cervical cancer screening programmes are opportunistic (on demand), although specific screening and follow-up guidelines for low-and high-risk women are followed. 17 Given that the screening programmes are opportunistic and given the change in the patterns of sexual behaviour in Spanish women (which may be the cause of the increasing incidence of HPV infections), it is of interest to know the frequency of cervical cytology testing and to assess the sociodemographic profiles that may influence adherence to early detection behaviours.
The study aims are: (i)to analyse the frequency of cervical cytology testing in women in Spain and to evaluate the evolution in the period from 2006 to 2014; (ii) to describe the sociodemographic profile of the women who are tested; and (iii) to determine the variables that influence having cytology tests performed.
Methods
This is a descriptive cross-sectional study. A total of 53 628 women aged 15 years and older residing in Spain were selected from the two main sources of data: the National Health Survey (NHS) 2006 18 The microdata files [18] [19] [20] [21] were downloaded and processed in a single database.
The dependent variables of the study were (i) cytology test performed; (ii) frequency of performing the test (less than 3 years, between 3 and 5 years, more than 5 years); and (iii) reason for performing the test ('for some problem, symptom, or illness'; 'on the advice of your primary care physician or specialist'; 'because you received a letter or phone call or was asked at your health centre if you wanted to be tested'; and 'other').
Sociodemographic variables included age, nationality, education level, social status, job, marital status, current cohabitation and residency.
Social class was stratified into three levels: high class (level I: directors and managers of companies with 10 or more employees and professionals with university degrees; level II: directors of companies with less than 10 employees and professionals with college diplomas); medium class (level III: intermediate occupations; level IV: workers in qualified technical occupations); and low class (level V: primary sector workers, level VI: unskilled workers). [18] [19] [20] [21] For the data analysis, we used IBM SPSS version 22.0 (IBM Corp., Armonk, NY, USA), a statistical program licensed for use from the Universidad de Castilla la Mancha (University of Castilla la Mancha). In the descriptive analysis of the qualitative variables, counts (n) and percentages (%) were used, and for the quantitative variables, means (m) and standard deviations (SD) were used. A 2 test was used for the comparison of categorical variables. A multiple logistic regression was performed to determine the influence of the variables in having a cytology test performed. The ORs were calculated with their confidence intervals. A level of significance was set at P = 0.05 for all tests and comparisons.
Results
The records of 53 628 women residing in Spain over 15 years of age were analysed, resulting in a mean age of 52.68 (SD AE 19.12). A total of 94.1% of the women were Spanish, 49.2% were married and 77.2% lived with a partner. Table 1 shows the sociodemographic variables with respect to the survey years (table 1) . Table 2 shows the cytology tests conducted in different years. There was a significant increase in cytology testing in 2014 with respect to the other years. In addition, in 2012 and 2014, the reasons for testing changed, increasing due to the receipt of a letter advising testing and due to symptomatology (table 2) .
There were differences in cytology testing according to the health service of the autonomous community to which the women belonged, with Catalonia and Madrid being the communities with the highest percentage and Ceuta and Melilla having the lowest (P < 0.001). Navarra was the community which there was a higher participation in cytology testing for the reason of receipt a letter; but this reason was not the principal one to participate in cytology testing. However, in spite of receipt a letter, Navarra had not higher prevalence in cytology testing. In general, in Spain, the principal reason of cytology testing was the advice of primary care physician or specialist (table 2) . Table 3 shows the sociodemographic variables associated with cytology testing. Women of lower class, of foreign origin and/or with less education had significantly fewer cytology tests, while women with university educations had significantly more tests. Figure 1 shows the women of total sample who received cytology testing less than 3 years ago, analysed by age group and year of survey. In the year 2014, there was an increase in the percentage of women aged 25-65 years old who had undergone cytology testing in the last 3 years.
Through logistic regression (table 4) , we studied the variables related to obtaining cytology tests. Women aged 25-65 years old were 5.13 times more likely to have a cytology test than women aged 15-24 years old (OR: 5.13; P < 0.001). The level of academic studies attained also influenced the cytology testing. Universityeducated women were 9.23 times more likely than those without education to receive cytology testing (P < 0.001), and women with baccalaureate degrees or vocational training were 8.2 times more likely than those without educations to receive cytology testing. Women of social classes I and II (high) were 1.2 times more likely to have a cytology test (P = 0.026) than those of low social class (V and VI). Women of Spanish origin were 1.74 times more likely to have a cytology test than those who, although residing in Spain, were of foreign origin (P < 0.001).
Discussion
To our knowledge, the present study is the first performed in Spain, at a national level, to assess the frequency and sociodemographic variables that influence cytology testing and their evolution over time. This study also outlines the profile of a woman who does not participate in cytology testing.
The data analysis showed that the frequency of cytology testing had increased. In 2014, more than 52% of women surveyed had undergone cytology testing in the previous three years. This increase could be due to since 2007, The Spanish Health System has included the free HPV vaccine among adolescent girls (ages 11-14). In addition, since then it has increased the information about the importance in the prevention and etiology of cervical cancer: both the HPV vaccine and the early detection of cervical cancer. 17, 22 Although coverage increased from 2006 to 2014 (from 66.3% to 73.2%), some Spanish studies have shown that 60% of women diagnosed with cervical cancer had not previously had any cytology testing. 23 The widespread and equitable implementation of effective interventions, including HPV vaccination and cervical cancer screening, could substantially reduce the incidence of cancer among women in both developed and developing countries. 24 Pap smears and HPV tests are performed for cervical cancer screening. Since the 1960 s, screening programmes 15, 16, 25 have been conducted in Europe and the United States of America, which may be opportunistic or population based.
In Spain, given that the incidence of cervical cancer is not very high, 5 the health system policy recommends screening opportunistically, 17 with the objective of 70% of women youngest 30 years having cytology tests every 3 years and women 30-65 years having HPV tests every 5 years. 17 From the records studied, 72% of the women had a cytology test, although opportunistic screening did not appear to reach the entire population, creating inequalities in its administration. Of the data analysed, the women that were tested less often included women of foreign origin and those living in Ceuta and Melilla (Spanish cities located in North Africa). These findings are in line with other studies in which women belonging to ethnic minorities are less likely to engage in prevention campaigns, including mammograms and cervical cytology tests. 26, 27 This difference may be due to poor access to health systems, lower socioeconomic levels, not understanding the language, and cultural differences, among other factors. 8, 25, [28] [29] [30] The profile of women who underwent the least amount of cytology tests in Spain, despite the fact that the health system is public, consisted of young women with a low level of education and low income and/or those who were foreign. 25, 30, 31 Other studies have suggested that increasing health knowledge in these groups could improve adherence to testing. 32 The latest recommendations of the European practice guidelines recommend cytology testing every 3 years for women from 25 to 29 years old, co-testing every 5 years from 30 years of age to 65 years, and concluding screening at age 65 if previous screenings were negative. In the study being presented, a reduction in cytology testing was observed in women over 65 years old, a fact that coincides with the latest European recommendations. 17, 33, 34 In the Netherlands, 15 the screening system is based on population coverage by inviting women to participate. In a study comparing the Netherlands screening programme with the USA opportunistic programme, 15 it was possible to see that the percentage of adherence to cervical cancer screening increased in the Netherlands, avoided an increase in cytology testing in the same person; the coverage of minority groups was facilitated and reduced the cost of performing unnecessary cytology tests; achieving the same detection rates of cervical cancer. 15 Opportunistic screening reduces coverage, increases inequality, and decreases effectiveness and efficiency, resulting in a higher cost. 15, 17 In addition to follow health policies, health professionals should try to improve the adherence of people who do not participate in screening activities. Several studies have shown that sending a letter to such people can improve adherence. 22, [35] [36] [37] Currently, in addition to the reminder letter, studies are being conducted to encourage participation in screening, including sending swabs for self-sampling at home. Data are contradictory in this regard. In Australia, cytology testing improved for both the self-sampling group and the group that was sent a reminder letter, being higher in the first group. 38 In Switzerland, these differences between self-sampling and getting a reminder letter were not observed, although coverage did increase. 36 In Finland, cytology testing increased for both the reminder and self-sampling groups. 39 It is very important that health professionals know how to recognize the variables that influence adherence to cytology testing. Therefore, communication skills are necessary, along with the capacity to capture information to increase women's knowledge regarding the aetiology of cervical cancer, HPV infection, prevention measures and early diagnosis.
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Strength and limitations
These results were obtained from the analysis of the records of the NHS and EHSS surveys, which did not allow the type of cytology test to be distinguished (i.e. pap smear or HPV test) because that question was not included in the questionnaires. In addition, the analysed data are self-reported information. The conclusions of the study refer exclusively to the scope described. On the other hand, the study has strength because, to our knowledge, it is one of the few with such a large sample size (53 628 women) that is updated and representative at the national level, which allows comparisons with similar environments in other Western societies. Note: Nagelkerke's R 2 : 0.224; OR: odds ratio; CI 95%: 95% confidence interval.
Conclusion
The incidence of cytology testing in Spain is greater than 70%, and its frequency has increased in the past few years. Since 2007, the Spanish Health System has included the free HPV vaccine among adolescent girls (ages [11] [12] [13] [14] [15] , increasing the information about prevention of cervical cancer. The cervical cancer screening programme in Spain is opportunistic, which increases access inequality. There are differences in the prevalence of cytology testing according to different health services and in different socioeconomic strata. The profile of women who obtain less cytology testing includes those of low socioeconomic status, those who lack education and those who are younger and/or foreign or ethnic minorities.
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Key points
This study clarifies the variables associated with adhesion to undergoing cytology tests for cervical cancer screening (women with lower educational level, low socioeconomic status, and younger) There are differences in the prevalence of cytology testing according to different health services and in different socioeconomic strata. This study shows the prevalence rates of women who participated in cytology testing from 2006 to 2014 in Spanish population.
